Novartis reported 3.23B in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Alcon AG ALC:SW 20M 209M
Amgen AMGN:US $ 2378M 1550M
AstraZeneca AZN:LN -1674000000 2.8B
Bayer BAYN:GR 530M 2.81B
Biogen BIIB:US $ 794M 308.3M
Bristol Myers Squibb BMY:US $ 1996M 281M
Eli Lilly And LLY:US $ 1476M 72.6M
Fresenius FRE:GR € 1008M 13M
Fresenius Medical Care FME:GR € 505M 80.78M
Galapagos GLPG:NA -78199000 31.45M
Genmab GEN:DC 890M 103M
Gilead Sciences GILD:US $ 3842M 1596M
GlaxoSmithKline GSK:LN 1.94B 263M
GRIFOLS GRF:SM € 250.6M 37.64M
H. Lundbeck A/S LUN:DC 526M 70M
Hikma Pharmaceutical HIK:LN 343M 34M
Johnson & Johnson JNJ:US $ 3849M 2813M
Lonza Group LONN:SW 317M 34M
Merck MRK:GR € 1047M 2M
Merk MRK:US $ 4826M 3212M
Novartis NOVN:VX 3.23B 246M
Novartis NVS:US $ 3233M 246M
Orion ORNBV:FH 57.3M 13.7M
Pfizer PFE:US $ 7647M 1733M
Philips PHIA:NA € 358M 273M
Recordati REC:IM 122.56M 2.92M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M